Quantitative Analysis of Lea and Leb Antigens in Human Saliva
Baojie Wang
Department of Legal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Search for more papers by this authorKazuko Akiyama
Department of Legal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Search for more papers by this authorCorresponding Author
Hiroshi Kimura MD, PhD
Department of Legal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Department of Legal Medicine Kurume University School of Medicine Kurume, Fukuoka 830, JapanSearch for more papers by this authorBaojie Wang
Department of Legal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Search for more papers by this authorKazuko Akiyama
Department of Legal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Search for more papers by this authorCorresponding Author
Hiroshi Kimura MD, PhD
Department of Legal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
Department of Legal Medicine Kurume University School of Medicine Kurume, Fukuoka 830, JapanSearch for more papers by this authorAbstract
We have measured the H type 1, Lea and Leb antigens in the saliva from 129 Japanese individuals by a time-resolved europium ion fluorometric immunoassay using artificial antigen-albumin complexes as the reference substances. We confirmed that the amount of Leb was larger than that of Lea in the saliva from secretors (Lea–b+) and vice versa in the saliva from nonsecretors (Lea+b–). Unexpectedly, we discovered appreciable amounts of Leb with small amounts of H type 1 in the saliva from the nonsecretors. The concentration of Leb was about 10, 6 and 35% of the concentration of the Lea in the saliva from the nonsecretors of the A, B and O groups, respectively. The possible formation of Leb from Lea, in addition to the formation of Leb from H type 1, in the salivary glands is discussed.
References
- 1 Watkins WM Blood group substances. Science 1966; 152: 172–181.
- 2 Lloyd KO Blood group antigens as markers for normal differentiation and malignant change in human tissues. Am J Clin Pathol 1987; 87: 129–139.
- 3 Watkins WM Biochemistry and genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet 1980; 10: 1–136.
- 4 Clausen H., Hakomori S. ABH and related his-to-blood group antigens: Immunochemical differences in carrier isotypes and their distribution. Vox Sang 1989; 56: 1–20.
- 5 Kelso J. Quantitative aspects of Lewis-secretor interaction in saliva. Vox Sang 1968; 14: 282–288.
- 6 Sturgeon P., Arcilla MB Studies on the secretion of blood group substances. I. Observations on the red cell phenotype Le(a+b+x+). Vox Sang 1970; 18: 301–322.
- 7 Arcilla MB, Sturgeon P. Studies on the secretion of blood group substances. II. Observations on the red cell phenotype Le(a-b-x-). Vox Sang 1973; 25: 72–87.
- 8 Good AH, Yau O., Lamontagne LR, Oriol R. Serological and chemical specificities of twelve monoclonal anti-Lea and anti-Leb antibodies. Vox Sang 1992; 62: 180–189.
- 9 Brockhaus M., Magnani JL, Blaszczyk M., Steplewski Z., Koprowski H., Karlsson KA, Larson G., Ginsburg V. Monoclonal antibodies directed against the human Leb blood group antigen. J Biol Chem 1981; 256: 13223–13225.
- 10 Messeter L., Brodin T., Chester MA, Karlsson KA, Zopf D., Lundblad A. Immunochemical characterization of a monoclonal anti-Leb blood grouping reagent. Vox Sang 1984; 46: 66–74.
- 11 Pak KY, Blaszczyk M., Herlyn M., Steplewski Z., Koprowski H. Identification and isolation of Lewis blood group antigens from human saliva using monoclonal antibodies. Hybridoma 1984; 3: 1–10.
- 12 Holburn AM, Masters CA The radioimmunoassay of serum and salivary blood group A and Lea glycoproteins. Br J Haematol 1974; 28: 157–167.
- 13 Takatori T., Tsutsubuchi Y., Terazawa K., Nagao M., Akabame H., Mikami H. Lewis typing of human saliva stains by enzyme-linked immunosorbent assay (ELISA) using monoclonal anti-Lea and anti-Leb antibodies. Forensic Sci Int 1990; 47: 261–268.
- 14 Nakajima T., Yazawa S., Miyazaki S., Furukawa K. Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva. J Immunol Methods 1993; 159: 261–267.
- 15 Berson SA, Yalow RS General principles of radioimmunoassay. Clin Chim Acta. 1968; 22: 51–69.
- 16 Björk S., Breimer ME, Hansson GC, Karlsson KA, Leffler H. Structures of blood group glycosphingolipids of human small intestine: A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotypes of the donor. J Biol Chem 1987; 262: 6758–6765.
- 17 Donald ASR A-active trisaccharides isolated from A1 and A2 blood group-specific glycoproteins. Eur J Biochem 1981; 120: 243–249.
- 18 Le Pendu J., Lemieux RU, Oriol R. Purification of anti-Lec antibodies with specificity for βDGal(1–3)βDGlcNAcO-using a synthetic immunoadsorbent. Vox Sang 1982; 43: 188–195.
- 19 Ørntoft TF, Holmes EH, Johnson P., Hakomori S., Clausen H. Differential tissue expression of Lewis blood group antigens: Enzymatic, immunologic, and immunochemical evidence for Lewis a and b antigen expression in Le(a–b–) individuals. Blood 1991; 77: 1389–1396.
- 20 Ernst C., Atkinson B., Wysocka M., Blaszczyk M., Herlyn M., Sears H., Steplewski Z., Koprowski H. Monoclonal antibody localization of Lewis antigen in fixed tissue. Lab Invest 1984; 50: 394–400.
- 21 Mollicone R., Bara J., Le Pendu J., Oriol R. Immunohistologic pattern of type 1 (Lea, Leb) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest 1985; 53: 219–227.
- 22 Limas C., Lange PH Lewis antigens in normal and neoplastic urothelium. Am J Pathol 1985; 121: 176–183.
- 23 Berg EL, Robinson MK, Mansson O., Butcher EC, Magnani JL A carbohydrate domain common to both sialyl Lea and sialyl Lex is recognized by the endothelial cell leucocyte adhesion molecule ELAM-1. J Biol Chem 1991; 266: 14869–14872.
- 24 Watkins WM Blood-group specific substances; in A. Gottschalk (ed): Glycoproteins. Their Composition, Structure and Function. BBA Library. Amsterdam, Elsevier, 1972, vol 5, pp 830–891.
- 25 Baig MM, Winzler RJ, Rennert OM Isolation of mucin from human submaxillary secretions. J Immunol 1973; 111: 1826–1833.
- 26 Shen L., Grollman EF, Ginsburg V. An enzymatic basis for secretor status and blood group substance specificity in humans. Proc Natl Acad Sci USA 1968; 59: 224–230.
- 27 Chester MA, Watkins WM α-L-Fucosyltransferases in human submaxillary gland and stomach tissues associated with the H, Lea, and Leb blood group characters and ABH secretor status. Biochem Biophys Res Commun 1969; 34: 835–842.
- 28 Yazawa S., Furukawa K. α-L-Fucosyltransferase related to biosynthesis of blood group substances in human saliva. J Immunogenet 1980; 7: 137–148.
- 29 Betteridge A., Watkins WM Variant forms of α-2-L-fucosyltransferase in human submaxillary glands from blood group ABH ‘secretor’ and ‘non-secretor’ individuals. Glycoconjugate J 1985; 2: 61–78.
- 30 Ørntoft TF, Wolf H., Watkins WM Activity of the human blood group ABO, H, Le and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium. Cancer Res 1988; 48: 4427–4433.
- 31 Ørntoft TF, Greenwell P., Clausen H., Watkins WM Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewisb blood group antigens in human colon by α-2-L-fucosyltransferase. Gut 1991; 32: 287–293.
- 32 Grollman EF, Kobata A., Ginsburg V. An enzymatic basis for Lewis blood types in man. J Clin Invest 1969; 48: 1489–1494.
- 33 Szulman AE, Marcus DM The histologic distribution of the blood group substances in man as disclosed by immunofluorescence. VI. The Lea and Leb antigens during fetal development. Lab Invest 1973; 28: 565–574.
- 34 Sakamoto J., Watanabe T., Tokumura T., Takagi H., Nakazato H., Lloyd KO Expression of Lewisa, Lewisb Lewisx, Lewisy, sialyl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 1989; 49: 745–752.
- 35 Torrado J., Blasco E., Cosme A., Gutierrez-Hoyos A., Arenas JI Expression of type 1 and type 2 blood group-related antigens in normal and neoplastic gastric mucosa. Am J Clin Pathol 1989; 91: 249–254.
- 36 Limas C. Detection of urothelial Lewis antigens with monoclonal antibodies. Am J Pathol 1986; 125: 515–523.
- 37 Nishi K., Fechner G., Rand S., Brinkmann B. Light-microscopic examination of ABH and Lewis antigens in human tracheal and epiglottic glands using the avidin-biotin-peroxidase complex technique. Z Rechtsmed 1989; 102: 255–262.
- 38 Pour PM, Tempero MM, Takasaki H., Uchida E., Takiyama Y., Burnett DA, Steplewski Z. Expression of blood group-related antigens ABH, Lewis a, Lewis b, Lewis X, Lewis Y and CA 19–9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res 1988; 48: 5422–5426.
- 39 Lemieux RU, Baker DA, Weinstein WM, Switzer CM Artificial antigens. Antibody preparations for the localization of Lewis determinants in tissues. Biochemistry 1981; 20: 199–205.
- 40 Chester MA, Yates AD, Watkins WM Phenyl β-D-galactopyranoside as an acceptor substrate for the blood-group H gene-associated guanosine diphosphate L-fucose: β-D-galactosyl α-2-L-fucosyltransferase. Eur J Biochem 1976; 69: 583–592.
- 41 Sarnesto A., Kohlin T., Thurin J., Blaszczyk-Thurin M. Purification of H gene-encoded β-galactoside α1–2 fucosyltransferase from human serum. J Biol Chem 1990; 265: 15067–15075.
- 42 Sarnesto A., Kohlin T., Hindsgaul O., Thurin J., Blaszczyk-Thurin M. Purification of the secretor type β-galactoside α1–2 fucosyltransferase from human serum. J Biol Chem 1992; 267: 2737–2744.
- 43 Liepkans VA, Larson G. Biosynthesis of Lewis fucolipid antigens in human colorectal carcinoma cells. Partial characterization of LeOse4Cer and H-1 fucolipid fucosyltransferase acceptor activities. Eur J Biochem 1987; 168: 209–217.
- 44 Prohaska R., Schenkel-Brunner H., Tuppy H. Enzymatic synthesis of blood-group Lewis-specific glycolipids. Eur J Biochem 1978; 84: 161–166.
- 45 Blaszczyk-Thurin M., Sarnesto A., Thurin J., Hindsgaul O., Koprowski H. Biosynthetic pathways for the Leb and Y glycolipids in the gastric carcinoma cell line KATO III as analyzed by a novel assay. Biochem Biophys Res Commun 1988; 151: 100–108.
- 46 Yazawa S., Nakamura J., Asao T., Nagamachi Y., Kanaya K., Tachikawa T., Matta KL The 65th annual meeting of the Japanese Biochemical Society (abstract) (in Japanese). Seikagaku 1992; 64: 821.